[Aojing Medical: The company was filed by the China Securities Regulatory Commission for allegedly falsely recording financial data in periodic reports and other reports] On November 1, Ajing Medical (688613.SH) announced that the company received the "Notification of Case Filing" from the China Securities Regulatory Commission on November 1, 2026. The China Securities Regulatory Commission decided to file a case against the company for allegedly falsely recording financial data such as periodic reports. If subsequent administrative penalties are determined to involve a major violation of the law and forced delisting, the company's stocks will be subject to a major violation of the law and forced delisting. The company's current operations and management are normal and it will actively cooperate with the investigation and fulfill its information disclosure obligations.